Today’s development depends on synthetic biology and efficient screening
The range of synthetic biology tools available for manipulating microbial metabolic pathways has expanded significantly in the past decade, opening new routes to chemical products. But the development challenges associated with strain development, as well as scaling up effective fermentation processes remain. Companies manufacturing biofuels, bio-based chemical intermediates, natural products and therapeutic proteins, are all capitalizing on powerful synthetic biology techniques to rationally engineer microbes, as well as seeking ways to use high-throughput screening systems that will expedite the development of robust and efficient cellular-production platforms and the effectiveness of process development and scaleup...
This information is only available to Gold members.
Forgot your user ID or password? Click here to have it sent to you.
Not a member yet?
UPGRADE now to full archive accces and you will receive:
A discount on full delegate pass to ChemInnovations.
Join other CPI professionals from all over the globe and share best practices, expertise, concerns and more.
Provide feedback to Chemical Engineering Editors
Current members represent Worley Parsons, DuPont, SABIC, Fluor, Air Products, LyondellBasell, Nalco, Dow Chemical, Dow Corning, BASF, Jacobs Engineering, ExxonMobil, Shell, Chevron and more.
